Home
News
296
Results found
-
GNA NOW Consortium announces positive results for the late preclinical development of the first-in-class antibiotic NOSO-502
The GNA NOW Consortium, which Lygature proudly coordinates, has reached an important milestone with the completion of the GLP toxicology studies for its NOSO-502 program. The results allow for the further development of the program to Phase 1. -
The Pediatric Praziquantel Consortium: an EDCTP and European Commission success story
The Pediatric Praziquantel Consortium, coordinated by Lygature, has been featured in the latest issue of the European & Developing Countries Clinical Trials Partnership (EDCTP) e-Magazine, with a focus on the work of the Consortium and interviews with two of its project members, Maurice Odiere (Kenya Medical Research Institute (KEMRI)) and Beatrice Greco (Merck). -
The MLC Foundation is looking for a senior lawyer data protection law
The MLC Foundation aims to contribute to the conduct of responsible, high-quality medical research and health care. It does this through research, advice, drawing up relevant documents (regulations / agreements) and maintaining bonds with relevant external parties. The MLC Foundation is looking for a senior lawyer data protection law. -
Register now for the combined FIGON Dutch Medicines Days / EUFEPS conference
The combined Dutch Medicine Days and EUFEPS Annual Meeting 2022 (June 1-3, in Leiden) is an important and interesting meeting that brings together all stakeholders in medicine research. We’d like to invite our network to register as soon as possible! -
Lygature congratulates Biotech Booster, Oncode-PACT and PharmaNL
The Dutch government invests €651 million in the life sciences & health-sector in the second round of the National Growth Fund.[1] The National Growth Fund was launched in 2020 to strengthen the earning power of the Netherlands. The Fund invests together with initiators in projects that generate sustainable economic growth on the long term. -
The launch of the European Innovative Health Initiative (IHI)
Lygature is an essential partner in European public-private partnerships that bring together the expertise and capability to solve complex health challenges. -
Lygature congratulates the Medicines Evaluation Board with its 1000th board meeting
Today, the 1000th board meeting of the Medicines Evaluation Board (College ter Beoordeling van Geneesmiddelen) will take place. Lygature congratulates the MEB with this special occasion. -
Scientific Advisory Board convenes for the fifth time
At the end of 2021, the Lygature Scientific Advisory Board convened for the fifth time. The meeting included two main topics: an update on the highlights and progress since the last meeting, and an outside-in discussion on scientific and societal trends. -
World TB Day 2022: Invest to End TB. Save Lives
Each year on 24 March, World Tuberculosis (TB) Day is commemorated to raise awareness of this devastating and deadly disease. -
Administration of antithrombotic drugs during catheter treatment of stroke is unsafe
Administration of antithrombotic drugs during catheter treatment of stroke patients leads to an increased risk of intracerebral hemorrhage, with no beneficial effect on recovery. The researchers, led by Erasmus MC, expect their results to change worldwide guidelines for administration of antithrombotic drugs during catheter treatment of stroke. -
New hope for cancer drugs thanks to European Lead Factory partnership
The European Lead Factory (ELF), a pan-European drug discovery project which Lygature proudly coordinates, has helped identify two drug candidates for cancer treatment that have now progressed to phase 1 clinical trial testing. -
Vacancy: Project Management Officer
Wij zijn op zoek naar een Project Management Officer (24-40 uur per week) -
UNITE4TB Community Advisory Group holds inaugural meeting
The UNITE4TB Community Advisory Group (CAG), which has been established to represent the views of the TB community at all stages of the project, met for the first time on Wednesday 16 February. -
UNITE4TB webinar: panel discussion on the global burden of TB
Registration is now open for the first UNITE4TB webinar focusing on the global burden of Tuberculosis (TB). -
Improving the regulatory system through collaboration
An interview with Pieter Stolk